Solutions for gene therapy using a deeper analytical characterization of AAV vector development

April 14, 2020

Gene therapy—a type of DNA-based medicine that utilizes a virus to insert a healthy gene into cells to replace a mutated, disease-causing variant has emerged as one of the most promising medical treatments. While great advances and successfully launched treatments are available, there is still a lot of work that needs to be done to better characterize and further optimize viral vectors.

We share examples of using Prometheus to precisely monitor and distinguish unfolding and aggregation behavior of different adeno-associated virus (AAV) serotypes. We will show how concentration, buffer formulation and various stresses influence the stability of viral particles. Together, these results enable scientists to screen, identify, characterize and select the top AAV candidates that can be developed into novel gene therapies with the greatest potency and highest efficacy.

Previous Video
Molecular tools to study viral infectious diseases
Molecular tools to study viral infectious diseases

Pandemics have affected human society throughout history, but with the current pandemic happening today, re...

Up next
Happy proteins make happy researchers, and how Tycho helps with that
Happy proteins make happy researchers, and how Tycho helps with that

How do you usually know whether your protein is happy? Even if you’re already using a portfolio of techniqu...


Sign up to receive
the latest NanoTemper news, product updates, event announcements and more

First Name
Last Name
Company Name
Agree to Subscribe & Privacy Policy*
*I have fully read, understood and agree to the Privacy Policy. I accept the storing and processing of my personal data by NanoTemper as described in the Privacy Policy.

By completing this form, you provide us consent to contact you with educational content, news and information about our products, services and events. You may unsubscribe at any time.
Thank you!
Error - something went wrong!